Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2021
Where the money goes
Where each dollar of revenue went, fiscal 2021
- Cost of revenue37¢$434.0K
- Research and development13¢$157.9K
- Other costs47¢$551.9K
- Income tax1¢$13.5K
- Profit1¢$15.8K
Out of $1.2M in revenue.2
Financial statements
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenue | $1.4M4 | $1.3M5 | $1.3M5 | $1.2M6 | $1.3M6 | $1.2M2 | $1.2M2 |
| Cost of revenue | $439.5K2 | $434.0K2 | |||||
| Gross profit | $932.4K4 | $923.2K5 | $916.3K5 | $822.2K6 | $868.9K6 | $797.9K2 | $739.2K2 |
| Research and development | $149.2K4 | $157.4K5 | $160.9K5 | $169.9K6 | $160.3K6 | $164.4K2 | $157.9K2 |
| Operating income | $156.0K4 | $145.2K5 | $148.6K5 | $32.4K6 | $100.3K6 | $49.5K2 | $17.5K2 |
| Income tax | $44.8K4 | $41.2K5 | $43.7K5 | $1.6K6 | $29.3K6 | $15.9K2 | $13.5K2 |
| Net income | $113.6K4 | $106.3K5 | $107.2K5 | $33.1K6 | $73.5K6 | $36.0K2 | $15.8K2 |
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Cash | $975.8K5 | $1.1M5 | $1.0M6 | $1.1M6 | $1.2M6 | ||
| Current assets | $1.3M4 | $1.4M5 | $1.5M5 | $1.6M6 | $1.6M6 | $1.7M2 | $1.7M2 |
| Total assets | $1.5M4 | $1.6M5 | $1.7M5 | $1.7M6 | $1.9M6 | $2.0M2 | $1.9M2 |
| Current liabilities | $76.2K4 | $69.2K5 | $71.7K5 | $70.6K6 | $156.3K6 | $166.8K2 | $127.5K2 |
| Shareholders’ equity | $1.4M5 | $1.5M5 | $1.6M6 | $1.6M6 | $1.7M2 | $1.7M2 | $1.7M2 |
| Shares outstanding | 14.9M shares4 | 14.9M shares4 | 14.9M shares5 | 14.9M shares6 | 14.9M shares2 |
What it owns
What BIOSYNERGY INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Machinery and equipment | $176.8K2 Apr 30, 2021 | $200.6K2 Apr 30, 2020 | −11.9% |
| Leasehold improvements | $25.8K2 Apr 30, 2021 | $25.8K2 Apr 30, 2020 | 0% |
| Property and equipment, before depreciation | $202.6K2 Apr 30, 2021 | $226.4K2 Apr 30, 2020 | −10.5% |
| Accumulated depreciation | $199.6K2 Apr 30, 2021 | $218.9K2 Apr 30, 2020 | −8.8% |
| Property and equipment, net | $3.1K2 Apr 30, 2021 | $7.5K2 Apr 30, 2020 | −59.3% |
| Operating-lease assets (leased space) | $96.6K2 Apr 30, 2021 | $193.1K2 Apr 30, 2020 | −50.0% |
Inventory
Leadership
Who has led BIOSYNERGY INC, and when. Pick a name to see everywhere that person has worked.
- PresidentBeverly Suzuki Jan 5, 2006 to Nov 14, 20069
- PresidentFred K. Suzuki Jan 5, 2006 to Nov 14, 200610
- PresidentLaurence Mead Jan 5, 2006 to Jan 5, 200611
- PresidentMary Friske Jan 5, 2006 to Jan 5, 200612
Board members and other officers (3)
- Board memberFred K. Suzuki Jan 5, 2006 to Nov 14, 200610
- Board memberJames Schembri Jul 28, 2006 to Jul 28, 200613
- Board memberBeverly Suzuki Nov 14, 2006 to Nov 14, 200614
Timeline
Filings
8 filings to the SEC since October 2021: 3 quarterly reports, 3 major events, 2 other. The latest 8:
- Apr 20, 202215-12G EDGAR
- Mar 28, 202210-Q/A EDGAR
- Mar 23, 202210-Q EDGAR
- Mar 17, 2022NT 10-Q EDGAR
- Jan 21, 20228-K EDGAR
- Jan 5, 20228-K EDGAR
- Dec 15, 202110-Q EDGAR
- Nov 30, 20218-K EDGAR
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
SEC filer profile
How BIOSYNERGY INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARBIOSYNERGY INC1
- CIK0000715812
- Employer ID (EIN)36-28809901
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inIllinois1
- Fiscal year endsApril 301
- Industry code (SIC)3829 Measuring & Controlling Devices, NEC1
- Business address55 West Monroe Street, Ste 1200, Chicago, IL 606031
- Phone84795604711
- Shares outstanding14,935,511 as of Jan 31, 20228
- Public float$0 as of Apr 30, 20212
- On EDGAR sinceSep 22, 19951
- Filings153 in all: 10-Q (63), 10-K (20), 10QSB (13), 8-K (13), 4 (9), 10-K/A (5), 10-Q/A (5), 10KSB (5)1
All 20 form types
UPLOAD (4), NT 10-K (3), 10KSB/A (2), 3 (2), NT 10-Q (2), 10-QT/A (1), 15-12G (1), 3/A (1), 4/A (1), CORRESP (1), NTN 10Q (1), SC 13D (1)
- Latest filingsAnnual report (10-K) Jul 29, 2021
Quarterly report (10-Q) Mar 23, 2022
Latest 8-K (8-K) Jan 21, 2022
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARBIOSYNERGY INC filings on SEC EDGAR
- 2SEC EDGARBIOSYNERGY INC 10-K for fiscal 2021
- 3SEC EDGARBIOSYNERGY INC filings on SEC EDGAR
- 4SEC EDGARBIOSYNERGY INC 10-K for fiscal 2015
- 5SEC EDGARBIOSYNERGY INC 10-K for fiscal 2016
- 6SEC EDGARBIOSYNERGY INC 10-K for fiscal 2018
- 7SEC EDGARBIOSYNERGY INC 10-Q for fiscal 2021
- 8SEC EDGARBIOSYNERGY INC 10-Q for fiscal 2022
- 9SEC EDGARBeverly Suzuki, President
- 10SEC EDGARFred K. Suzuki, President
- 11SEC EDGARLaurence Mead, President
- 12SEC EDGARMary Friske, President
- 13SEC EDGARJames Schembri, Board member
- 14SEC EDGARBeverly Suzuki, Board member
- 15
- 16SEC EDGAREntered a material agreement
- 17SEC EDGAREntered a material agreement